This paper is concerned with exploring the implications of replicability issues over the medical innovation process. Each research setting is characterized by a specific level of replicability, variability increasing with the complexity of the testing settings. The study introduces new measures...

This paper reports on the findings of interviews conducted with Hungarian firms on their overall business and innovation strategies and innovation activities to pursue three interconnected aims: a) better understand firm behaviour by analysing qualitative features of innovation processes...

This study deals with the organization of industry-science collaboration in the case of knowledge transfer for radical innovation. Based on a contingency notion, the relation between research and development (R&D) projects’ properties and the way of collaboration is explored. By means of...

This essay reviews Michael Carrier's recent book, Innovation in the 21st Century. While the book is well-written and full of accessible content, it nevertheless fails in its ambitious effort to defend the concept of an antitrust-relevant "innovation market." The essay notes that there is...

This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the diversity of a firm's product portfolio. More specifically, we try to explain large firms' expansion into new product markets driven by the characteristics of their technological...

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...

In the context of the ongoing debate about an innovation crisis in the pharmaceutical industry, we study the success rates of pharmaceutical R&D projects as a measure of innovative productivity. The empirical literature suggests success rates have been decreasing during recent decades. We...

In this paper we investigate the existence and evolution of bioeconomic projects of OMV Group, a major global player in the oil and gas industry. We further study the intellectual capital components utilized by OMV Group in supporting these bioeconomic actions. We conduct a longitudinal case...

This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the diversity of a firm's product portfolio. More specifically, we try to explain large firms' expansion into new product markets driven by the characteristics of their technological...